NCI Explores AI to Screen For and Treat Pancreatic Cancer
The institute sees the emerging technology supporting treatment for patients by better controlling tumor growth.
A new initiative at the National Cancer Institute aims to create capabilities for detecting pancreatic cancer early and improving treatments for patients with mutations.
A big challenge with pancreatic cancer resides in the KRAS gene. When mutated, the gene can cause normal cells to become cancerous. A new therapy involving KRAS inhibitors and genetic testing can help patients screen for this earlier.
Dr. Christine Alewine, the NIH Lasker Scholar in the Laboratory of Molecular Biology at NCI’s Center for Cancer Research, discussed this breakthrough, how new advancements can serve as an alternative treatment for chemotherapy and where AI can make an impact. Plus, she notes how other health issues such as diabetes also plays a role in screening for pancreatic cancer.
-
Dr. Christine Alewine NIH Lasker Scholar in the Laboratory of Molecular Biology, Center for Cancer Research NCI
-
Spain’s Cyber Agency is Incubating Businesses to Protect NATO Cyberspace
INCIBE Secretary General Carla Redondo Galbarriatu said the private sector is key to strengthening cybersecurity.
12m listen -
DHS AI Board Sees Civil Rights as ‘Part and Parcel’ of AI Safety
Secretary Alejandro Mayorkas shared details about the new board's first meeting and how he sees it transforming the agency's AI development.
3m read -
Cyber Strategy 2.0 Stresses Critical Infrastructure Protections
A year after its release, the second cybersecurity strategy and implementation plan focus on new initiatives for critical infrastructure.
5m read -
National Cyber Strategy Enables FBI to Disrupt Cybercriminals
The White House plan helped amplify and clarify the Bureau's role in law enforcement efforts, FBI Cyber DAD Cynthia Kaiser says.
13m listen